pluripotent

(redirected from Pluripotent stem cell)
Also found in: Medical.

plu·rip·o·tent

 (plə-rĭp′ə-tənt)
adj.
Relating to or being a cell that is capable of differentiating into cells of any type of tissue except placental tissue.

[Latin plūs, plūr-, more, many; see pelə- in Indo-European roots + potent.]

plu·rip′o·ten·cy (-tən-sē) n.

pluripotent

(ˌplʊrɪˈpəʊtənt)
adj
(Biology) biology capable of differentiating into different types of body cell
Translations

plu·rip·o·tent

, pluripotential
a. pluripotencial, que puede tomar más de un curso de acción.
References in periodicals archive ?
More precisely, he examines the role and contribution of law--in terms of its norms, concepts, rationalities, techniques, practices, and language--to the policy construction of artefacts like the embryo, animal chimeras, and cytoplasmic hybrids in human pluripotent stem cell research through the work of bioethical bodies like the Bioethics Advisory Committee in Singapore.
INTRODUCTION: Induced pluripotent stem cells (Also known as iPS cells or iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells.
The European human pluripotent stem cell registry (EU-hPSCreg) will adapt its registration content and requirements to accommodate hESC and hiPSC.
The final chapters address stem cell patents and the ethics of human pluripotent stem cell research and development.
However, in line with the WARF decision, if the pluripotent stem cell is removed at some stage in the development of the human body, and the removal results in the destruction of that stage of the human body, the pluripotent stem cell is not patentable.
4m to support the initial development of immune-evasive pluripotent stem cell lines, it was reported on Friday.
In a second step the researchers investigated what happens when somatic cells that normally neither have E-cadherin nor are pluripotent are reprogrammed into a pluripotent stem cell state.
The volume will be a valuable reference resource for both experienced investigators pursuing stem cell and induced pluripotent stem cell research as well as those new to this field.
The focus of the project will be to genetically engineer the company's CyT49 pluripotent stem cell line.
But further research of the complex regulation of pluripotent stem cell identity revealed unexpected difficulties.
Editing the pluripotent stem cell genome relies heavily on the survival of single cells to establish clonal cell lines.
The teratoma assay requires animal testing and a time span of six to eight weeks before scientists can prove that they have a pluripotent stem cell line.